Compare ARK Genomic Revolution ETF (ARKG) vs Clorox Co (CLX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Clorox Co — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Clorox Co trades at $96.55 (market cap $11.68B). The key difference: Clorox Co pays a 5.14% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Clorox Co nearer its low. Which is the better fit depends on your goals.
| ARKG | CLX | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $131.43 |
52-Week Low | $23.09 | $86.12 |
Market Cap | — | $11.68B |
Enterprise Value | — | $14.98B |
Dividend Yield | — | 5.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Clorox (CLX) trades at $96.56, up 3.75% today, but remains down over 7% YTD amid declining sales and profitability concerns. The stock shows a bearish technical trend with key support at $91, while fundamentals reveal strong profitability with an 11.18% net margin and a 5.5% dividend yield. Recent corporate actions include a simplified operating structure and CEO transition, with Q2 2026 earnings pending.
The outlook is mixed: a high dividend and recent earnings beats offer value, but bearish analyst sentiment and sales declines pose risks. Upside exists if restructuring drives growth, yet investor caution is warranted given valuation premiums and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →
